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SUMMARY
Here, we show that b adrenergic signaling coordinately upregulates de novo lipogenesis (DNL) and thermo-
genesis in subcutaneous white adipose tissue (sWAT), and both effects are blocked in mice lacking the
cAMP-generating G protein-coupled receptor Gs (Adipo-GsaKO) in adipocytes. However, UCP1 expression
but notDNLactivation requires rapamycin-sensitivemTORC1.Furthermore,b3-adrenergic agonistCL316243
readily upregulates thermogenic but not lipogenic genes in culturedadipocytes, indicating that additional reg-
ulators must operate on DNL in sWAT in vivo. We identify one such factor as thyroid hormone T3, which is
elevated locally by adrenergic signaling. T3 administration to wild-type mice enhances both thermogenesis
and DNL in sWAT. Mechanistically, T3 action on UCP1 expression in sWAT depends upon cAMP and is
blocked in Adipo-GsaKO mice even as elevated DNL persists. Thus, T3 enhances sWAT thermogenesis by
amplifying cAMP signaling, while its control of adipocyte DNL can be mediated independently of both
cAMP and rapamycin-sensitive mTORC1.
INTRODUCTION
When exposed to cold temperatures, mammals elicit a coordi-
nated physiological response aimed at maintaining their body
temperature. This adaptive thermogenic response is initiated by
the central (CNS) and sympathetic (SNS) nervous systems to
elevate uncoupling protein 1 (UCP1) and heat generation in
‘‘beige’’ adipocytes within subcutaneous white adipose tissue
(sWAT) and brown adipose tissue (BAT) (Cannon and Neder-
gaard, 2004; Nedergaard and Cannon, 2014). Adipose nerve fi-
bers play a pivotal role in these processes, as disruption of adi-
pose sympathetic innervation impairs lipolysis as well as
thermogenesis and induces obesity and glucose intolerance in
rodents (Bartness et al., 2014; Cannon and Nedergaard, 2004;
Guilherme et al., 2019; Jiang et al., 2017; Pereira et al., 2017;
Schulz et al., 2013). Cold exposure also elicits significant in-
creases in adipocyte glucose and lipid metabolism, including
glucose uptake, fatty acid oxidation, and fatty acid biosynthesis
(called de novo lipogenesis [DNL]) (Cannon and Nedergaard,
2004; Orava et al., 2011; Yu et al., 2002). Such activation of the
opposing pathways of DNL and fatty acid oxidation has been
suggested as amechanism to ensure the availability of fatty acids
as fuel tobeoxidized, providing energy for heat productionduring
thermogenesis (Mottillo et al., 2014; Yu et al., 2002). However,
DNL and fatty acid oxidation in other cell types are normally regu-
lated in a reciprocal fashion through the inhibition of the mito-
chondrial fatty acid uptake Cpt1 proteins by the DNL intermedi-
ate malonyl-coenzyme A (CoA), which attenuates fatty acid
oxidation (Foster, 2012). In the liver, for example, this regulation
ensures a predominance of the activity of one pathway over the
other (Foster, 2012). The distinctive cellular signaling pathways
that coordinate the simultaneous upregulation of both DNL and
fatty acid oxidation within sWAT and BAT are not known.
Canonically, the sympathetic neurotransmitter norepinephrine
(NE) signals through the cAMP pathway in adipocytes to upregu-
late lipolysis and UCP1, as well as other mitochondrial proteins
that mediate fatty acid oxidation (Cannon and Nedergaard,
2004; Collins, 2012). NE activates b-adrenergic receptors
(b-ARs), through which the G protein-coupled receptor Gsa
stimulates adenylate cyclase and cyclic AMP (cAMP) produc-
tion, activating the protein kinase A (PKA) pathway (Collins,
2012; Guilherme et al., 2019). Accordingly, sWAT sympathetic
denervation (Bartness et al., 2014) or genetic deletion of adipo-
cyte Gsa (Li et al., 2016) suppresses lipolysis and adipose ther-
mogenesis. Furthermore, signaling by PKA through the mecha-
nistic target of rapamycin complex 1 (mTORC1) pathway is
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required for optimal thermogenic responses in adipose tissue
(Chen et al., 2018; Liu et al., 2016; Tran et al., 2016). Although
less is known about the CNS regulation of adipocyte DNL, func-
tional adipose sympathetic fibers also appear necessary for
such regulation. Hypothalamic administration of insulin or leptin
upregulatesWATDNL, and these effects are blocked by adipose
sympathetic nerve fiber ablation (Buettner et al., 2008; Scherer
et al., 2011). Sympathetic stimulation of DNL in BAT from cold-
exposed rodents has also been previously demonstrated (San-
chez-Gurmaches et al., 2018; Trayhurn, 1979, 1980; Yu et al.,
2002). Furthermore, pharmacological activation of the b3-AR in
mice mimics cold exposure in activating both thermogenesis
and DNL in sWAT and BAT (Lee et al., 2017; Mottillo et al.,
2014). Recent data indicate that lipolysis stimulation is required
for the optimal upregulation of UCP1 in sWAT (Mottillo et al.,
2014), but whether the b-AR-cAMP-PKA pathway is essential
for the activation of sWAT DNL during adaptive thermogenesis
is less clear. These findings indicate that the SNS controls the
simultaneous activation of synthesis and oxidation of fatty acids
in sWAT and BAT in the cold, but the upstream signaling ele-
ments that are required for DNL regulation and how they are in-
tegrated with those that control thermogenesis are not well
understood.
Based on the above considerations, the aim of the present
studies was to determine how upstream b-AR signaling path-
ways coordinately control thermogenesis versus DNL. We
focused on sWAT since the expansion of beige adipocytes ex-
pressing UCP1 within sWAT depots in humans and rodents dur-
ing cold exposure indicates that they have important roles to play
in systemic metabolism (Hepler et al., 2017; Ikeda et al., 2018;
Langin, 2010). Recent work demonstrating the ability of beige
adipocytes to secrete factors beneficial to overall glucose ho-
meostasis has amply reinforced this concept (Kajimura et al.,
2015; Min et al., 2016). In this article, we report that during
cold acclimation, the signaling pathways to enhance UCP1
and DNL gene expression diverge following cAMP generation.
While adrenergic upregulation of both UCP1 and DNL genes
are abolished in mice deficient in adipose tissue Gsa, rapamycin
treatment to inhibit mTORC1 selectively inhibits the former.
Furthermore, our findings indicate that the activation of adipose
sympathetic activity stimulates local production of the thyroid
hormone T3 (triiodothyronine) to induce DNL in sWAT. Thus, syn-
thesis and oxidation of fatty acids in sWAT are simultaneously
enhanced by the sustained activation of b3-AR and T3 hormone
receptor (TR) signaling. However, in contrast to thermogenesis,
control of adipocyte DNL by TR signaling can be mediated inde-
pendently of cAMP. This cooperation between sympathetic
nerve activity and thyroid hormone receptor signaling to promote
both fatty acid biosynthesis and oxidation in adipose tissue may
be critical to ensure lipid production as fuel for thermogenesis.
RESULTS
Expression of Genes Related to Both Fatty Acid
Synthesis and Oxidation Are Coordinately Regulated by
Sympathetic Nerve Activity in sWAT
Initial experiments were conducted to confirm the hypothesis
that adipose SNS activity drives both thermogenesis and DNL
gene expression in sWAT during cold exposure. Housing mice
at 6C for 2 weeks strongly activated the expression of lipogenic
transcriptional factor ChREBPb and the DNL genes fatty acid
synthase (Fasn), ATP-citrate lyase (Acly), acetyl-CoA-carbox-
ylase-2 (Acacb), and stearoyl-CoA-desaturase (Scd1) (Figures
1A and 1C) in concert with the expected upregulation of thermo-
genesis-related genes Ucp1, Cidea, and Pgc1a (Figures 1B and
1C) in sWAT. The appearance of multilocular beige adipocytes
within the sWAT of these cold-exposed mice in conjunction
with the appearance of UCP1 and FASN protein was also readily
observed (Figure 1D). To test the requirement of sympathetic
nerve activity for these effects, sWAT depots in mice were
injected with vehicle (control mice) or 6-hydroxydopamine
(6-OHDA) (denervated mice) in advance of 6C cold challenge
for 7 days. As shown in Figures 1E and 1F, the sympathetic nerve
marker tyrosine hydroxylase (TH) was greatly reduced by the
6-OHDA treatment, indicating that denervation was extensive,
while the cold-induced increased expression of genes related
to both DNL and thermogenesis was virtually abolished. In addi-
tion, sympathetic denervation reduced the appearance of multi-
locular adipocytes that contain FASN and UCP1 (Figure 1G). We
have used mechanical denervation of sWAT as an additional
approach to validate the results obtained using chemical dener-
vation. Both chemical and mechanical denervations of sWAT
greatly reduce the enhancement of DNL-related gene expres-
sions upon cold stimulus (data not shown).
These results show that there is strong upregulation of DNL
gene expression in sWAT concomitant with enhanced thermo-
genesis during cold exposure in mice, and that both of these re-
sponses are similarly dependent upon sympathetic signaling.
b3-AR Activation Rescues Adipose DNL at
Thermoneutrality
To test whether sympathetic neurotransmitter signaling through
adrenergic receptors is sufficient to stimulate DNL during 6C
cold exposure, we tested the effects of the b3-AR agonist
CL316243 (CL) injected into mice. As depicted in Figures 2A
and 2B, a 6-day treatment of mice at room temperature (RT)
with CL stimulated the expression of several DNL-related genes
in sWAT and gonadal adipose tissue (eWAT, data not shown) de-
pots to an extent that is similar to cold stimulus (compare to Fig-
ures 1 and 2). Among these genes are the lipogenic transcrip-
tional factor ChREBPb and the DNL enzymes Acly, Fasn,
Acacb, Scd1, and Elovl6, and they are selectively upregulated
in the adipocytes, but not in the stromal vascular fraction (SVF)
(Figure 2C). Similar data were obtained for thermogenic gene
expression (Figures 2A–2C). To test the effect of CL in the virtual
absence of sympathetic signaling,micewere housed for 6weeks
at 30C (thermoneutrality [TN]). This greatly decreased the
expression of DNL genes in both BAT (Figures 2D and 2E) and
sWAT (Figures 2F and 2G) and caused a ‘‘whitening’’ of BAT (Fig-
ure 2H). The administration of CL to mice at TN caused a sharp
increase in the expression of DNL genes FASN and ACLY (Fig-
ures 2D–2G) and ‘‘browning’’ of both BAT and sWAT with
increased multilocularity in the latter (Figures 2H and 2I). These
data confirm that pharmacological stimulation of b3-AR in mice
at RT or TN activates DNL in subcutaneous adipocytes,
mimicking the stimulatory effect of cold exposure.
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Adipocyte cAMP Signaling Is Essential for the b3-AR-
Mediated Activation of DNL
Canonically, b3-AR signaling occurs via activation of Gsa-type G
proteins, followed by the stimulation of adenylyl cyclase and an
increased production of intracellular cAMP to regulate protein
phosphorylation and gene transcription (Cannon and Neder-
gaard, 2004; Collins, 2012; Li et al., 2016; Reverte-Salisa et al.,
2019). To establish whether cAMP signaling is required for b3-
AR-mediated activation of DNL gene expression in adipocytes,
we used mice with the genetic deletion of Gsa selectively in ad-
ipocytes by crossing Gsa-Flox/Flox mice with adiponectin-Cre
mice to generate Adipo-GsaKO (knockout) mice, as previously
described (Li et al., 2016). Gsa protein levels were reduced in ad-
ipocytes from sWAT (Figures 3A and 3B) and BAT (Figure S1),
but not in adipose-derived SVFs (Figure 3B) or other tissues in
Adipo-GsaKO mice, such as the liver (Figure S2), confirming
the selective deletion of Gsa in adipocytes. Adipocyte lipolysis
relies on b3-AR stimulation of the cAMP-PKA pathway to
enhance perilipin phosphorylation and triglyceride (TAG) hydro-
lysis in response to CL (Li et al., 2016; Zechner et al., 2012), and
accordingly, the levels of circulating free fatty acids (FFAs) were
significantly reduced in Adipo-GsaKO (Figure 3C), as previously
described (Li et al., 2016). While CL treatment enhanced the
expression of several DNL-related genes in sWAT from control
Gsa-Flox/Flox mice, the effects were not recapitulated in
Adipo-GsaKO mice (Figures 3A–3E). Moreover, the b3-AR-
induced expression of thermogenic genes in control mice,
such as Ucp1, Cidea, Ppargc1a, Pparg2, and Pdk4, were sup-
pressed in the sWAT and BAT of Adipo-GsaKO mice (Figures
3A, 3F, and S1), confirming an essential role of cAMP signaling
in adipose thermogenesis (Li et al., 2016; Paulo et al., 2018; Re-
verte-Salisa et al., 2019). Thus, cAMP signaling in adipocytes is
indispensable for b3-AR-mediated activation of DNL in adipo-
cytes, as it is for thermogenesis.
A B
C D
E
F G
Figure 1. Cold-Stimulated Sympathetic
Drive Enhances DNL Gene Expressions
along with the Thermogenic Program in
WAT
(A) qRT-PCR depicting enhanced DNL gene
expression in sWAT from male mice housed at
22C or 6C for 2 weeks.
(B) qRT-PCR showing enhanced thermogenic
gene expression in sWAT from mice housed at
6C. qRT-PCR was performed for the quantifica-
tion of indicated mRNA expressions in sWAT from
cold-exposed wild-type mice.
(C) Western blots of sWAT lysates from mice
housed at 22C or 6C for 2 weeks, depicting
enhanced expression of ACLY, FASN, UCP1, and
GAPDH protein levels in cold-exposed mice.
GAPDH was used as loading control.
(D) Immunohistochemistry (IHC) for the detection
of UCP1 or FASN content in sWAT from mice
housed at 22C or 6C for 2 weeks. Scale bar,
100 mm. Graphs show the means ± SEMs. n = 12
mice per group.
(E) Adipose sympathetic denervation inhibits cold-
induced adipose DNL gene expressions. qRT-PCR
was performed to quantify Acly, Fasn, Ucp1, and
Cidea mRNA expression levels in sWAT from
control mice kept at room temperature (22C),
control mice cold exposed at 6C for 1 week, and
6-OHDA-denervated mice cold exposed at 6C for
1 week.
(F) Western blots to detect ACLY, FASN, TH,
UCP1, and GAPDH (loading control) protein levels
in sWAT from vehicle-injected control mice kept at
22C or 6C for 1 week and chemically denervated
mice exposed to cold (6C) for 1 week.
(G) Representative IHC analysis for the detection of
UCP1 and FASN protein in sWAT from vehicle-in-
jected and chemically denervated mice cold
exposed at 6C for 1 week. Scale bar, 100 mm.
Graphs show the means ± SEMs. n = 6–8 mice per
group. *p < 0.05 and **p < 0.01 byMann-WhitneyU
test (A and B) or by 1-way ANOVA, followed by
Tukey’s post hoc test (E).
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mTORC1 Is Not Essential for b3-AR-Induced
Adipose DNL
Based on our previous findings that the mTORC1 is necessary
for b3-AR to induce thermogenesis in sWAT (Chen et al., 2018;
Liu et al., 2016; Tran et al., 2016) and about the well-known
role of mTORC1 in regulating the DNL pathway in adipocytes
and other cell types (Caron et al., 2015; Crewe et al., 2019; Czech
et al., 2013; Danai et al., 2013; Feng et al., 2015; Han and Wang,
2018; Li et al., 2010; Peterson et al., 2011; Song et al., 2018;
Youn et al., 2019), we investigated whether mTORC1 is also
required for b3-AR regulation of DNL gene expression in WAT.
Mice were treated with rapamycin (2.5 mg/kg body weight per
day) once per day for 2 consecutive days, before and during a
7-day 4C cold challenge, as previously described (Liu et al.,
2016). Under these experimental conditions, rapamycin treat-
ment inhibited the cold-stimulated mTORC1 signaling pathway
Figure 2. b3-Adrenergic Receptor (b3-AR) Agonist CL316243 Treatment Rescues the Adipose DNL Genes in Thermoneutral Mice
(A) qRT-PCR was performed for quantification of the indicated genes in sWAT depot from wild-type male mice housed at 22C and treated with vehicle or with
CL316243 for 6 days.
(B) Western blots of sWAT lysates from vehicle-treated and CL316243-treated mice depicting enhanced expression of FASN, ACC, ACLY, MCAD, and UCP1
proteins in CL-treated mice. GAPDH was used as loading control.
(C) b3-AR activation promotes DNL in adipocytes. qRT-PCR to quantify Acly, Fasn, or Ucp1mRNA expressions in adipocytes or in stromal vascular fraction (SVF)
isolated from the sWAT of mice treated or not treated with CL316243 for 6 days.
(D–G) CL316243 treatment rescues the adipose DNL genes in thermoneutral mice. Adipose DNL is suppressed when SNS outflow and b3-AR activation in AT are
negligible. (D) qRT-PCR to quantify Fasn and Acly mRNA levels in BAT from mice housed at 22C or 30C for 5 weeks and then treated or not treated with
CL316243 for 6 days. Immunoblot depicting FASN protein levels in BAT (E) or sWAT (G) frommice housed at 22C or 30C treated with vehicle or with CL316243.
(F) FASN and ACLY protein levels were quantified by densitometry from the immunoblot data shown in (G).
(H and I) CL316243 treatment restores adipose DNL in thermoneutral mice. IHC to detect FASN in BAT (H) and sWAT (I) from mice kept at 22C or 30C and
treated or not treated with CL316243 for 6 days. Scale bar, 100 mm.
Graphs show the means ± SEMs. n = 5–6 mice per group. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by Mann-Whitney U test.
A B C
D
E F
Figure 3. The cAMP Production in Adipocytes Is Required for b3-AR-Induced Lipogenic Gene Expression in sWAT
(A) Gsa-protein inactivation in adipocytes strongly inhibits the b3-mediated stimulation of DNL and induction of browning in sWAT. Depicted are representative
western blots for lipogenic (ACLY and FASN) and thermogenic protein (UCP1) expression in sWAT from Gsa-Flox/Flox control and adipocyte-specific GsaKO
mice (Adipo-GsaKO) treated with vehicle or with CL316243 for 6 days. GAPDH was used as loading control.
(B) Isolated adipocytes (Adipo) and stromal vascular fractions (SVFs) from Gsa-Flox/Flox or Adipo-GsaKO mice were immunoblotted for Gsa protein.
(C) The effect of adipocyte Gsa inactivation on circulating non-esterified fatty acids (NEFAs) is depicted. *p < 0.05 by Student’s t test.
(D) Quantifications of proteins from the western blots depicted in (A).
(E and F) qRT-PCR analysis to quantify lipogenic (E) and thermogenic (F) gene expressions in sWAT fromGsa-Flox/Flox control and Adipo-GsaKOmice treated or
not treated with CL316243.
Graphs show the means ± SEMs. n = 8 mice per group.
(D–F) *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by 1-way ANOVA, followed by Tukey’s post hoc group comparisons.
See also Figures S1 and S2.
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in adipose cells, as previously demonstrated by reductions in ri-
bosomal S6 protein phosphorylation levels (Liu et al., 2016).
However, while rapamycin-mediated mTORC1 inhibition signifi-
cantly reduced the stimulatory effects of cold on the expressions
of UCP1 in sWAT (Figures 4A and 4B), as previously reported (Liu
et al., 2016), rapamycin treatment had no effect on cold-stimu-
lated ACLY, FASN, and acetyl-CoA carboxylase (ACC) protein
levels (Figures 4A and 4B). Furthermore, while mTORC1 inhibi-
tion via rapamycin completely blocked the CL-mediated induc-
tion of the thermogenic mediator UCP1, rapamycin failed to
inhibit DNL gene expression in sWAT (Figures 4C–4E) and other
adipose tissue depots under these same conditions (Figure S3).
These results indicate a bifurcation in the b3-AR-cAMP signaling
pathways that mediate the induction of the thermogenic gene
program versus DNL in sWAT.
b3-AR Signaling Upregulates UCP1 Expression but Fails
to Promote Adipose DNL In Vitro
Thedata in Figures 1, 2, 3, and4 indicate thatb3-ARactivation sig-
nals through cAMP to stimulate adipocyte DNL gene transcription
in vivo. Therefore, the question of whether b3-AR signaling acti-
vates DNL in adipocytes in vitro through a cell-autonomousmech-
anism was addressed. To this end, mature 3T3-L1 adipocytes
were treatedwithvehicleorwith100nMCLfor the indicatedperiod
(Figure 5A), showing that CL treatment failed to drive DNL gene
expression. In fact, stimulation with CL significantly reduced the
expression of several DNL-related genes in this adipocyte cell
line (Figure 5A). In contrast, CL treatment strongly upregulated
the expression of the thermogenic genes Ucp1, Ppara, and
Pgc1a in 3T3-L1 adipocytes (Figure 5B). Consistent with these re-
sults in 3T3-L1 adipocytes, the treatment of primary adipocytes
in vitro with CL also failed to increase the expression of DNL-
related genes ACLY and FASN (Figure 5D), while PKA activation
and stimulation of thermogenic gene expression were readily
observed in these CL-treated primary adipocytes (Figures 5C–
5E). These data are consistent with the hypothesis that although
activation of PKA is sufficient to drive UCP1 expression in adipo-
cytes, other factors or pathways are required to stimulate DNL-
related gene expression.
T3 Signaling Enhances cAMP Signaling and Is Essential
for b3-AR-Induced DNL in Adipocytes
We identified thyroid hormone T3 as a potential factor that may
be independently required for optimal DNL regulation in sWAT
A B
C D E
Figure 4. Rapamycin Treatment Fails to Block the b3-AR-Stimulated DNL Gene Expression in WAT
(A) Rapamycin treatment inhibits cold-inducedUCP1 expression, but not the DNL gene expression in sWAT.Western blots for the detection of DNL (FASN, ACLY,
and ACC) and thermogenic (UCP1) proteins and actin (loading control) in sWAT from control mice (22C) andmice exposed to 4C for 1 week, treated with vehicle
or rapamycin.
(B) Quantification from protein bands depicted in western blots from (A).
(C) Representative western blots to detect FASN, ACLY, UCP1, and GAPDH (loading control) proteins in sWAT from control and CL316243-treated mice, co-
treated or not with rapamycin.
(D) Quantification of protein bands shown in western blots from (C).
(E) qRT-PCR analysis of indicated DNL and thermogenic gene expression in sWAT from CL-treated mice, with or without rapamycin.
Graphs show the means ± SEMs. n = 6–8 mice per group.
(B, D, and E) *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by 1-way ANOVA, followed by Tukey’s test for group comparisons.
See also Figure S3.
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Figure 5. CL316243 Treatment In Vitro Failed to Induce DNL Gene Expression in Cultured Adipocytes
(A and B) qRT-PCR analysis of DNL (A) and thermogenic (B) gene expression in 3T3-L1 adipocytes (day 7 post-differentiation) treated with CL316243 (100 nM) for
the indicated time points.
(C–E)Western blots for the detection of phospho-PKA substrates and GAPDH (loading control) protein levels in cultured primary adipocytes treated or not treated
with different doses (0, 1, and 100 nM) of CL316243 for 6 h (C). Also depicted are qRT-PCR quantifications to determine the expression levels of Fasn and Acly (D)
and Ucp1, Ppara and Pgc1a (E) mRNA in cultured primary adipocytes treated with indicated doses of CL316243 for 6 h.
Graphs show the means ± SEMs. n = 3 determinations. *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001.
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based on previous data indicating that the thyroid hormone T3
can regulate lipogenesis in BAT (Bianco et al., 1998; Christoffo-
lete et al., 2004). AR signaling has been shown to enhance BAT
production of T3 through the upregulation of BAT Dio2 (iodothyr-
onine deiodinase 2), which locally converts circulating T4
(thyroxine) to T3 (de Jesus et al., 2001; Silva and Larsen, 1983,
1985). Consistent with these studies, Dio2 expression levels
were reduced in BAT and sWAT from Adipo-GsaKO mice (Fig-
ures S4B and S4C). Also, a similar increase in Dio2 in sWAT ad-
ipocytes (Figure S4A) was observed in our experiments in
response to cold (Figure 6A) or CL (Figure 6B), suggesting
increased local T3 concentrations. Conversely, synergism be-
tween sympathetic signaling and thyroid hormone is known to
occur through T3 potentiation of cAMP production in response
to AR activation (Carvalho et al., 1996; Rubio et al., 1995a,
1995b). This concept is depicted in Figure 6K. T3 administration
A B C D
F G
H
I J K
Figure 6. Thyroid Hormone Signaling Is Essential for b3-AR-Induced DNL in Adipocytes
(A and B) Cold stimulus and CL316243 treatment enhance the expression levels of T3-producing enzyme iodothyronine deiodinase-2 (Dio2) in sWAT. Mice were
housed at 30C, 22C for 8weeks, or exposed to 6C for 2weeks (A) or housed at 22Cand treatedwith vehicle or with CL316243 for 6 days (B).Dio2mRNA levels
in sWAT were then quantified by qRT-PCR.
(C) Wild-type mice were maintained on a control diet or iodine-deficient + PTU diet to inhibit thyroid hormone production. Mice were then treated or not treated
with CL316243 to evaluate adipose b3-AR signaling in hypothyroid mice. Depicted is the diagram representing the experimental design.
(D and E) Iodine-deficient + PTU diet feeding strongly reduces the circulating levels of T4 (D) and T3 (E).
(F) Representative western blots to detect FASN, ACLY, UCP1, HSL, phospho-HSL, and HSP-90 (loading control) proteins in sWAT from euthyroid and hypo-
thyroid mice treated with vehicle or with CL316243 or T3, as indicated.
(G) Quantification from protein bands depicted in western blots from (F).
(H) qRT-PCR quantifications to determine the expression levels of Fasn, Acly, and Ucp1 mRNAs in sWAT from euthyroid and hypothyroid mice treated or not
treated with the indicated agonists.
(I and J) Representative IHC analyses for the detection of UCP1 and FASN proteins in sWAT from euthyroid mice (I) or hypothyroid mice (J), treated or not treated
with the indicated agonist. Scale bar, 100 mm.
(K) Proposed model depicting the feedforward cycle whereby cAMP and T3 amplify each other’s activity.
Graphs show themeans ± SEMs. n = 5mice per group. In (A) and (D)–(H), *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 by 1-way ANOVA, followed by post
hoc group comparisons. In (B), *p < 0.05 by Student’s t test. See also Figure S4.
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to wild-type mice enhanced the cAMP signaling pathway in
sWAT under the conditions of our experiments, as evidenced
by the potentiation of phosphorylation of downstream substrates
of PKA (phospho-HSL and phospho-CREB) in response to CL
administration (Figures 6F and S4B). In the same experiments,
T3 treatment of mice also elevated UCP1, FASN, and ACLY pro-
tein levels. These results are consistent with a large body of work
(Carvalho et al., 1996; Rubio et al., 1995a, 1995b), underscoring
the feedforward cycle whereby cAMP and T3 amplify each
other’s activity (Figure 6K).
We next explored the dependency of AR signaling on thyroid
hormone to thermogenesis (UCP1 expression), lipolysis (phos-
pho-HSL), and DNL genes in a hypothyroidmousemodel. As de-
picted in Figures 6D and 6E, circulating levels of T4 and T3 were
strongly reduced in mice rendered hypothyroid with iodine-defi-
cient + propylthiouracil (PTU) diet feeding. Moreover, CL treat-
ment did not affect the plasma levels of T3 or T4 in euthyroid
or hypothyroid mice, while the circulating levels of T3 were
increased in both euthyroid and hypothyroid mice treated with
T3, as expected.
As shown in Figure 6F, both CL and T3 treatment elicited
strong upregulation of FASN and ACLY proteins in sWAT from
euthyroid mice. CL administration completely failed to stimulate
the expressions of FASN and ACLY in the sWAT of hypothyroid
mice, showing that T3 signaling is required for b3-AR activation
of DNL genes in these adipocytes. Consistent with this notion,
co-administration of CL and T3 into hypothyroidmice completely
rescued the b3-AR-stimulated FASN, ACLY, ChREBPb, GLUT4,
ACC2, and SCD1 expressions in sWAT (Figures 6F–6H and S4E).
Similarly, b3-AR activation by CL failed to induce UCP1 expres-
sion in sWAT from hypothyroid mice (Figures 6F–6H), while co-
administration of CL and T3 rescued the UCP1 upregulation in
sWAT. The formation of UCP1+ and FASN+ multilocular adipo-
cytes elicited by CL treatment was also completely suppressed
in hypothyroid mice, while the co-administration of T3 restored
the formation of such cells (Figures 6I and 6J). These results
suggest that thyroid hormone T3 enhances cAMP signaling
and is indispensable for optimal b3-AR stimulation of PKA,
DNL, thermogenic gene expression, and browning of sWAT in
subcutaneous adipocytes.
Figure 7. Triiodothyronine (T3) Treatment Partially Restores DNL in Adipocytes without cAMP
(A) Representative western blots for lipogenic (FASN, ACLY, ACC, and SCD1) and thermogenic protein (UCP1) expression in sWAT from Gsa-Flox/Flox control
and Adipo-GsaKOmalemice treatedwith vehicle or with T3 for 10 days. Nitrocellulosemembranewas also stainedwith Ponceau S to confirm the equal loading of
total protein.
(B) Quantification of protein bands from western blots depicted in (A). Shown are the incremental increases in FASN, ACLY, ACC, SCD1, and UCP1 proteins due
to T3 treatment over those in the respective vehicle lanes. Graphs depict the means ± SEMs. n = 3–4 mice per group. *p < 0.05.
(C) Representative IHC analyses for the detection of UCP1 and FASN proteins in sWAT fromGsa-Flox/Flox control and Adipo-GsaKOmice treated with vehicle or
with T3 for 10 days. Scale bar, 100 mm.
(D) Proposed model shows how b3-AR and thyroid hormone signal integration controls thermogenesis (UCP1) and de novo lipogenesis (FASN) in adipocytes.
Both thermogenesis and T3-induced DNL are driven by b3-AR signaling intrinsically.
See also Figures S5 and S6.
Cell Reports 31, 107598, May 5, 2020 9
Article
ll
OPEN ACCESS
T3 Treatment Partially Restores DNL but Not
Thermogenesis in Adipocytes Independently of cAMP
Having established that effective CL signaling in sWAT absolutely
requires T3 function, we sought to answer the converse question:
is T3 able to enhance DNL in sWAT independent of cAMP
signaling? To address this issue, control and Adipo-GsaKO
mice were treated with daily doses of vehicle or T3 for 10 days.
As depicted in Figures 7A and 7B, T3 treatment of Gsa-Flox/
Flox mice upregulated FASN and UCP1 protein expression in
sWAT, which is consistent with the results observed in wild-
type euthyroid mice shown in Figure 6. In contrast, the loss of
cAMP production by adipocyte inactivation of Gsa completely
blocked the stimulatory effect of T3 on UCP1 expression in
sWAT (Figures 7A and 7B). In agreement with the UCP1 immuno-
blot in Figure 7A, the formation of UCP1+ multilocular adipocytes
was also suppressed in sWAT from Adipo-GsaKO mice (Fig-
ure 7C). Treatment with T3 to a large extent rescued the inhibition
of FASN, ACLY, ACC, and SCD1 protein expressions due to the
lack of cAMPproduction (Figures 7A and 7B). Thus, the incremen-
tal increase in FASN, ACLY, ACC, and SCD1 protein expressions
in response to T3 in Adipo-GsaKO mice was similar to what is
observed in control mice (Figure 7B). While the effect of T3 treat-
ment on UCP1 expression was minimal in adipocytes lacking
cAMP, this hormone enhanced DNL gene expressions in adipo-
cytes despite the absence of cAMP. These results suggest that
while the transcriptional regulation of UCP1 by T3 requires
cAMP, the activation of DNL enzymes by this hormone can occur
independently of cAMP signaling. Therefore, these results are
consistent with a working model whereby b3-AR-mediated local
T3 production stimulates the transcriptional activity of TRs to pro-
mote the expression of DNL-related genes and potentiates the
cAMP-PKA pathway that is essential for thermogenic gene
expression in adipocytes (Figure 7D).
To further investigate whether the lack of proper CL and T3 re-
sponses observed in the constitutive Adipo-GsaKO mice were
due to developmental issues that arise from the absence of
cAMP in adipocytes at an early life stage, we generated a tamox-
ifen-inducible KO mouse model of Gsa deficiency called induc-
ible Adipo-GsaKO (iAdipo-GsaKO). We then conducted experi-
ments wherein Gsa protein deletion was induced in adipocytes
by treating mature adult iAdipo-GsaKO mice with tamoxifen,
as depicted in Figure S6A. Twoweeks post-tamoxifen injections,
mice were then treated or not treated with CL316243 or with T3
and the effect of these agonists on UCP1 expression in sWAT
evaluated. As shown in Figure S6, tamoxifen treatment inhibited
the Gsa expression levels in sWAT from iAdipo-GsaKO, but not
Gsa-Flox/Flox mice. Both CL316243 and T3 failed to induce
UCP1 expression in sWAT from iAdipo-GsaKO, suggesting
that early developmental defects that may hypothetically arise
from early cAMP deficiency do not account for the inhibition of
the T3 response (Figures 3, 7, and S6). Moreover, these findings
further reinforce the essential role played by cAMP during T3/TR
signaling to promote UCP1 expression in white adipocytes.
Also, if permanent developmental disruptions occurred in the
constitutive Adipo-GsaKO mice that disrupted cell responsive-
ness, then such adipocytes from these mice should not respond
to acute stimulation by cAMP itself (e.g., an acute rescue). To
address this question, adipose tissue explants excised from the
Adipo-GsaKO mice were acutely incubated with dibutyryl cAMP
in vitro to test whether they would regain responsiveness. As
shown inFigureS5, adipose tissuedepletedofGsaprotein treated
withdibutyryl-cAMP,butnotwithb3-agonistCL, regained respon-
siveness, as both PKA activity and lipolysis were stimulated by di-
butyryl cAMP treatment. Moreover, UCP1 expression in subcu-
taneous adipocytes lacking Gsa was strongly stimulated by
dibutyryl-cAMP treatment, but not by CL. These results suggest
that nonspecific cellular deficiencies due to the absence of
cAMP in adipocytes during development is not the cause of
blockade in T3 actions on thermogenesis in sWAT.
DISCUSSION
The main findings presented here demonstrate an obligatory link
between signaling by sympathetic nerve fibers in adipose tissue
via the b3-AR-cAMP-PKA pathway and T3/TR signaling to pro-
mote both thermogenesis and DNL in sWAT during cold expo-
sure. b3-AR agonist administration cannot stimulate either
UCP1 expression or DNL gene expression in sWAT in the
absence of thyroid hormone, while T3 administration rescues
these responses (Figure 6). Our results reveal that the relation-
ship between the cAMP pathway and T3 signaling differs mech-
anistically for UCP1 versus DNL gene regulation. In the case of
UCP1 expression, the major role of T3 is to amplify cAMP
signaling (Figure 6F), likely by increasing the generation of
cAMP itself. Thus, T3 administration has little effect on its own
to enhance UCP1 expression in the absence of cAMP signaling,
as observed in Adipo-GsaKO mice (Figures 7A–7C and S6) or
following induction of the Gsa in mature iAdipo-GsaKO mice
(Figure S6). In contrast, b3-AR-cAMP-PKA signaling to elevate
DNL gene expression appears to be driven to a large extent
through the DIO2-mediated conversion of T4 to T3 (Figure 6A),
which can elevate FASN and other DNL enzymes independent
of cAMP (Figure 7).
It is noted that previous work by several laboratories (Finan
et al., 2016; Johann et al., 2019; Lin et al., 2015; Matesanz
et al., 2017) has shown that T3 and TR agonists stimulate
sWAT thermogenesis in the absence of b3-AR agonists, and
that this can occur even when mice are housed at TN (Johann
et al., 2019; Lin et al., 2015). This work has suggested the idea
that T3 may act on UCP1 expression independent of the cAMP
pathway. However, none of these studies tested the effects of
TR agonists in mice deficient in the ability to produce cAMP,
as we present here. Thus, our data make the important point
that T3 actions on sWAT thermogenesis cannot occur in the total
absence of cAMP and that further work is necessary to fully un-
derstand the molecular basis for this relationship between cAMP
and T3 actions in sWAT.
Increased local production of T3 in BAT via the sympathetic
activation of DIO2 has been described in previous reports (de
Jesus et al., 2001; Silva and Larsen, 1983, 1985). Genetic dele-
tion of DIO2 completely abolishes the activation of DNL in brown
adipocytes from mice exposed to 4C (Christoffolete et al.,
2004). Consistent with a significant role of TRs in the regulation
of adipocyte fatty acid biosynthesis, several DNL-related genes,
such as ChREBP, Fasn, Acaca, Me, Thrsp, and Slc2a4, present
TR-binding sites in their promoter regions (thyroid-responsive
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elements [TREs]), and their expressions in BAT and in white ad-
ipocytes are upregulated by thyroid hormone treatment both
in vivo and in vitro (Bianco et al., 1998; Blennemann et al.,
1995; Katz et al., 2018; Moustaı¨d and Sul, 1991; Obregon,
2014). Moreover, conversion of 14C-glucose into TAGs and fatty
acids are enhanced in sWAT from mice treated with T3 and b3-
AR agonist CL (Figure S4). Thus, the increases in the expression
of DNL genes in response to T3 and CL are accompanied by the
expected increase in metabolic flux through the DNL pathway.
These results suggest that adipose sympathetic drive relies on
both b3-AR and TR signaling in an integrated mode to optimally
activate adipocyte DNL gene expression and DNLmetabolic flux
during adaptive thermogenesis (Figure 7D).
The concept that a bifurcation in cAMP signaling related to
UCP1 versus DNL gene expression occurs at relatively early
steps in the pathway is also consistent with our findings on the
role of mTORC1 in these processes. Previous work by us (Liu
et al., 2016) and others (Chen et al., 2018; Tran et al., 2016)
has demonstrated that mTORC1 (mTOR and Raptor) operates
downstream of b3-AR and is essential for adipose thermogene-
sis and browning induced by b3-AR activation. Based on the re-
sults of many studies indicating a regulatory role of mTORC1 to
control DNL in the liver (Caron et al., 2015; Feng et al., 2015; Han
andWang, 2018; Li et al., 2010; Peterson et al., 2011; Youn et al.,
2019) and adipose tissue (Crewe et al., 2019; Czech et al., 2013;
Danai et al., 2013; Song et al., 2018), it seemed likely that
mTORC1 may also mediate the stimulatory effect of b3-AR on
adipocyte DNL. This does not seem to be the case, as rapamycin
treatment of mice completely blocked cold-induced UCP1
expression in sWAT but failed to blunt the activation of adipose
DNL by cold exposure (Figure 4). Therefore, rapamycin-sensitive
mTORC1 activities that mediate the effects of b3-AR activation
on adaptive adipose thermogenesis are not essential for b3-AR
to activate sWAT DNL at cold temperatures. These findings are
consistent with the concept that T3 primarily enhances the early
steps of cAMP signaling (Figure 7D).
While the present studies were directed to early events that
control DNL gene expression in response to SNS activation,
clearly, the mechanisms at play at the transcriptional level are
also crucial to a full understanding of DNL regulation. It is of inter-
est that DNL gene regulation is also under the control of insulin
signaling (Czech, 2017; Czech et al., 2013; Guilherme et al.,
2017), suggesting that there may be additional coordinated inte-
gration of T3 action with the downstream effects of insulin. Addi-
tional research on how transcriptional regulators are coordi-
nately controlled by inputs from cAMP, insulin, and T3 to
control DNL genes will be of great interest to the field.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d RESOURCE AVAILABILITY
B Lead Contact
B Material Availability
B Data and Code Availability
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILS
B Adipose Tissue Denervation
B Animal Housing at Thermoneutral Temperature and
b3-AR-agonist Treatment
B Rapamycin Treatment
B Hypothyroid Mouse Model and T3 Treatment
B Lipogenesis Assay
B Adipocyte Cell Cultures
B Dibutyryl-cAMP Treatment
B Western Blot Analysis
B RNA Isolation and RT-qPCR
B Histological Analysis
d QUANTIFICATION AND STATISTICAL ANALYSIS
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.
celrep.2020.107598.
ACKNOWLEDGMENTS
We thank all of themembers of Michael Czech’s lab for helpful discussions and
critical reading of the manuscript. We thank the University of Massachusetts
Morphology Core for assistance in the immunohistochemistry analysis. This
work was supported by NIH grants DK30898 and DK116056 to M.P.C.,
R01DK116625 to S.C. and American Diabetes Association Minority Postdoc-
toral Fellowship 1-19-PMF-035 to F.H.
AUTHOR CONTRIBUTIONS
A.G. and M.P.C. wrote the manuscript. A.G., A.H.B., B.Y., F.H., D.L., S.C., and
M.P.C. designed the research. A.G., A.H.B., B.Y., F.H., D.L., A.L., L.G., S.M.N.,
andM.K. performed the experiments. L.W. andM.C. designed the Gsa-Floxed
mouse model that was used in the research.
DECLARATION OF INTERESTS
The authors declare no competing interests.
Received: October 1, 2019
Revised: February 24, 2020
Accepted: April 10, 2020
Published: May 5, 2020
REFERENCES
Bartness, T.J., Liu, Y., Shrestha, Y.B., and Ryu, V. (2014). Neural innervation of
white adipose tissue and the control of lipolysis. Front. Neuroendocrinol. 35,
473–493.
Bianco, A.C., Carvalho, S.D., Carvalho, C.R., Rabelo, R., and Moriscot, A.S.
(1998). Thyroxine 50-deiodination mediates norepinephrine-induced lipogen-
esis in dispersed brown adipocytes. Endocrinology 139, 571–578.
Blennemann, B., Leahy, P., Kim, T.S., and Freake, H.C. (1995). Tissue-specific
regulation of lipogenic mRNAs by thyroid hormone. Mol. Cell. Endocrinol. 110,
1–8.
Buettner, C., Muse, E.D., Cheng, A., Chen, L., Scherer, T., Pocai, A., Su, K.,
Cheng, B., Li, X., Harvey-White, J., et al. (2008). Leptin controls adipose tissue
lipogenesis via central, STAT3-independent mechanisms. Nat. Med. 14,
667–675.
Cannon, B., and Nedergaard, J. (2004). Brown adipose tissue: function and
physiological significance. Physiol. Rev. 84, 277–359.
Cell Reports 31, 107598, May 5, 2020 11
Article
ll
OPEN ACCESS
Caron, A., Richard, D., and Laplante, M. (2015). The Roles of mTOR Com-
plexes in Lipid Metabolism. Annu. Rev. Nutr. 35, 321–348.
Carvalho, S.D., Bianco, A.C., and Silva, J.E. (1996). Effects of hypothyroidism
on brown adipose tissue adenylyl cyclase activity. Endocrinology 137, 5519–
5529.
Chen, S., Mei, X., Yin, A., Yin, H., Cui, X.B., and Chen, S.Y. (2018). Response
gene to complement 32 suppresses adipose tissue thermogenic genes
through inhibiting b3-adrenergic receptor/mTORC1 signaling. FASEB J. 32,
4836–4847.
Christoffolete, M.A., Linardi, C.C., de Jesus, L., Ebina, K.N., Carvalho, S.D., Ri-
beiro, M.O., Rabelo, R., Curcio, C., Martins, L., Kimura, E.T., and Bianco, A.C.
(2004). Mice with targeted disruption of the Dio2 gene have cold-induced over-
expression of the uncoupling protein 1 gene but fail to increase brown adipose
tissue lipogenesis and adaptive thermogenesis. Diabetes 53, 577–584.
Collins, S. (2012). -Adrenoceptor Signaling Networks in Adipocytes for Re-
cruiting Stored Fat and Energy Expenditure. Front. Endocrinol. (Lausanne) 2,
102.
Crewe, C., Zhu, Y., Paschoal, V.A., Joffin, N., Ghaben, A.L., Gordillo, R., Oh,
D.Y., Liang, G., Horton, J.D., and Scherer, P.E. (2019). SREBP-regulated
adipocyte lipogenesis is dependent on substrate availability and redox modu-
lation of mTORC1. JCI Insight 5, 129397.
Czech, M.P. (2017). Insulin action and resistance in obesity and type 2 dia-
betes. Nat. Med. 23, 804–814.
Czech, M.P., Tencerova, M., Pedersen, D.J., and Aouadi, M. (2013). Insulin
signalling mechanisms for triacylglycerol storage. Diabetologia 56, 949–964.
Danai, L.V., Guilherme, A., Guntur, K.V., Straubhaar, J., Nicoloro, S.M., and
Czech, M.P. (2013). Map4k4 suppresses Srebp-1 and adipocyte lipogenesis
independent of JNK signaling. J. Lipid Res. 54, 2697–2707.
Danai, L.V., Flach, R.J., Virbasius, J.V., Menendez, L.G., Jung, D.Y., Kim, J.H.,
Kim, J.K., and Czech, M.P. (2015). Inducible Deletion of Protein Kinase
Map4k4 in Obese Mice Improves Insulin Sensitivity in Liver and Adipose Tis-
sues. Mol. Cell. Biol. 35, 2356–2365.
de Jesus, L.A., Carvalho, S.D., Ribeiro, M.O., Schneider, M., Kim, S.W., Har-
ney, J.W., Larsen, P.R., and Bianco, A.C. (2001). The type 2 iodothyronine de-
iodinase is essential for adaptive thermogenesis in brown adipose tissue.
J. Clin. Invest. 108, 1379–1385.
Feng, D., Youn, D.Y., Zhao, X., Gao, Y., Quinn, W.J., 3rd, Xiaoli, A.M., Sun, Y.,
Birnbaum, M.J., Pessin, J.E., and Yang, F. (2015). mTORC1 Down-Regulates
Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC). PLoS One 10,
e0126240.
Finan, B., Clemmensen, C., Zhu, Z., Stemmer, K., Gauthier, K., Muller, L., De
Angelis, M., Moreth, K., Neff, F., Perez-Tilve, D., et al. (2016). Chemical Hybrid-
ization of Glucagon and Thyroid Hormone Optimizes Therapeutic Impact for
Metabolic Disease. Cell 167, 843–857.e14.
Foster, D.W. (2012). Malonyl-CoA: the regulator of fatty acid synthesis and
oxidation. J. Clin. Invest. 122, 1958–1959.
Guilherme, A., Pedersen, D.J., Henchey, E., Henriques, F.S., Danai, L.V., Shen,
Y., Yenilmez, B., Jung, D., Kim, J.K., Lodhi, I.J., et al. (2017). Adipocyte lipid
synthesis coupled to neuronal control of thermogenic programming. Mol.
Metab. 6, 781–796.
Guilherme, A., Henriques, F., Bedard, A.H., and Czech, M.P. (2019). Molecular
pathways linking adipose innervation to insulin action in obesity and diabetes
mellitus. Nat. Rev. Endocrinol. 15, 207–225.
Han, J., and Wang, Y. (2018). mTORC1 signaling in hepatic lipid metabolism.
Protein Cell 9, 145–151.
Hepler, C., Shao, M., Xia, J.Y., Ghaben, A.L., Pearson, M.J., Vishvanath, L.,
Sharma, A.X., Morley, T.S., Holland, W.L., and Gupta, R.K. (2017). Directing
visceral white adipocyte precursors to a thermogenic adipocyte fate improves
insulin sensitivity in obese mice. eLife 6, e27669.
Ikeda, K., Maretich, P., and Kajimura, S. (2018). The Common and Distinct
Features of Brown and Beige Adipocytes. Trends Endocrinol. Metab. 29,
191–200.
Jiang, H., Ding, X., Cao, Y., Wang, H., and Zeng, W. (2017). Dense Intra-adi-
pose Sympathetic Arborizations Are Essential for Cold-Induced Beiging of
Mouse White Adipose Tissue. Cell Metab. 26, 686–692.e3.
Johann, K., Cremer, A.L., Fischer, A.W., Heine, M., Pensado, E.R., Resch, J.,
Nock, S., Virtue, S., Harder, L., Oelkrug, R., et al. (2019). Thyroid-Hormone-
Induced Browning of White Adipose Tissue Does Not Contribute to Thermo-
genesis and Glucose Consumption. Cell Rep. 27, 3385–3400.e3.
Kajimura, S., Spiegelman, B.M., and Seale, P. (2015). Brown and Beige Fat:
Physiological Roles beyond Heat Generation. Cell Metab. 22, 546–559.
Katz, L.S., Xu, S., Ge, K., Scott, D.K., and Gershengorn, M.C. (2018). T3 and
Glucose Coordinately Stimulate ChREBP-Mediated Ucp1 Expression in
Brown Adipocytes From Male Mice. Endocrinology 159, 557–569.
Langin, D. (2010). Recruitment of brown fat and conversion of white into brown
adipocytes: strategies to fight the metabolic complications of obesity? Bio-
chim. Biophys. Acta 1801, 372–376.
Lee, Y.H., Kim, S.N., Kwon, H.J., and Granneman, J.G. (2017). Metabolic het-
erogeneity of activated beige/brite adipocytes in inguinal adipose tissue. Sci.
Rep. 7, 39794.
Li, S., Brown, M.S., and Goldstein, J.L. (2010). Bifurcation of insulin signaling
pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not
inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. USA 107, 3441–3446.
Li, Y.Q., Shrestha, Y.B., Chen,M., Chanturiya, T., Gavrilova, O., andWeinstein,
L.S. (2016). Gsa deficiency in adipose tissue improves glucose metabolism
and insulin sensitivity without an effect on body weight. Proc. Natl. Acad.
Sci. USA 113, 446–451.
Lin, J.Z., Martago´n, A.J., Cimini, S.L., Gonzalez, D.D., Tinkey, D.W., Biter, A.,
Baxter, J.D., Webb, P., Gustafsson, J.A., Hartig, S.M., and Phillips, K.J. (2015).
Pharmacological Activation of Thyroid Hormone Receptors Elicits a Functional
Conversion of White to Brown Fat. Cell Rep. 13, 1528–1537.
Liu, D., Bordicchia, M., Zhang, C., Fang, H., Wei, W., Li, J.L., Guilherme, A.,
Guntur, K., Czech, M.P., and Collins, S. (2016). Activation of mTORC1 is
essential for b-adrenergic stimulation of adipose browning. J. Clin. Invest.
126, 1704–1716.
Livak, K.J., and Schmittgen, T.D. (2001). Analysis of relative gene expression
data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.
Methods 25, 402–408.
Matesanz, N., Bernardo, E., Acı´n-Pe´rez, R., Manieri, E., Pe´rez-Sieira, S., Her-
na´ndez-Cosido, L., Montalvo-Romeral, V., Mora, A., Rodrı´guez, E., Leiva-
Vega, L., et al. (2017). MKK6 controls T3-mediated browning of white adipose
tissue. Nat. Commun. 8, 856.
Min, S.Y., Kady, J., Nam, M., Rojas-Rodriguez, R., Berkenwald, A., Kim, J.H.,
Noh, H.L., Kim, J.K., Cooper, M.P., Fitzgibbons, T., et al. (2016). Human ‘brite/
beige’ adipocytes develop from capillary networks, and their implantation im-
proves metabolic homeostasis in mice. Nat. Med. 22, 312–318.
Mottillo, E.P., Balasubramanian, P., Lee, Y.H., Weng, C., Kershaw, E.E., and
Granneman, J.G. (2014). Coupling of lipolysis and de novo lipogenesis in
brown, beige, and white adipose tissues during chronic b3-adrenergic recep-
tor activation. J. Lipid Res. 55, 2276–2286.
Moustaı¨d, N., and Sul, H.S. (1991). Regulation of expression of the fatty acid
synthase gene in 3T3-L1 cells by differentiation and triiodothyronine. J. Biol.
Chem. 266, 18550–18554.
Nedergaard, J., and Cannon, B. (2014). The browning of white adipose tissue:
some burning issues. Cell Metab. 20, 396–407.
Obregon, M.J. (2014). Adipose tissues and thyroid hormones. Front. Physiol.
5, 479.
Orava, J., Nuutila, P., Lidell, M.E., Oikonen, V., Noponen, T., Viljanen, T., Schei-
nin, M., Taittonen, M., Niemi, T., Enerba¨ck, S., and Virtanen, K.A. (2011).
Different metabolic responses of human brown adipose tissue to activation
by cold and insulin. Cell Metab. 14, 272–279.
Paulo, E., Wu, D., Wang, Y., Zhang, Y., Wu, Y., Swaney, D.L., Soucheray, M.,
Jimenez-Morales, D., Chawla, A., Krogan, N.J., and Wang, B. (2018). Sympa-
thetic inputs regulate adaptive thermogenesis in brown adipose tissue through
cAMP-Salt inducible kinase axis. Sci. Rep. 8, 11001.
12 Cell Reports 31, 107598, May 5, 2020
Article
ll
OPEN ACCESS
Pedersen, D.J., Guilherme, A., Danai, L.V., Heyda, L., Matevossian, A., Cohen,
J., Nicoloro, S.M., Straubhaar, J., Noh, H.L., Jung, D., et al. (2015). Amajor role
of insulin in promoting obesity-associated adipose tissue inflammation. Mol.
Metab. 4, 507–518.
Pereira, M.M., Mahu´, I., Seixas, E., Martine´z-Sa´nchez, N., Kubasova, N., Pirz-
galska, R.M., Cohen, P., Dietrich, M.O., Lo´pez, M., Bernardes, G.J., and Dom-
ingos, A.I. (2017). A brain-sparing diphtheria toxin for chemical genetic abla-
tion of peripheral cell lineages. Nat. Commun. 8, 14967.
Peterson, T.R., Sengupta, S.S., Harris, T.E., Carmack, A.E., Kang, S.A., Balde-
ras, E., Guertin, D.A., Madden, K.L., Carpenter, A.E., Finck, B.N., and Sabatini,
D.M. (2011). mTOR complex 1 regulates lipin 1 localization to control the
SREBP pathway. Cell 146, 408–420.
Reverte-Salisa, L., Sanyal, A., and Pfeifer, A. (2019). Role of cAMP and cGMP
Signaling in Brown Fat. Handb. Exp. Pharmacol. 251, 161–182.
Rodbell, M. (1964). Metabolism of Isolated Fat Cells. I. Effects of Hormones on
Glucose Metabolism and Lipolysis. J. Biol. Chem. 239, 375–380.
Rubio, A., Raasmaja, A., Maia, A.L., Kim, K.R., and Silva, J.E. (1995a). Effects
of thyroid hormone on norepinephrine signaling in brown adipose tissue. I.
Beta 1- and beta 2-adrenergic receptors and cyclic adenosine 30,50-mono-
phosphate generation. Endocrinology 136, 3267–3276.
Rubio, A., Raasmaja, A., and Silva, J.E. (1995b). Thyroid hormone and norepi-
nephrine signaling in brown adipose tissue. II: Differential effects of thyroid
hormone on beta 3-adrenergic receptors in brown and white adipose tissue.
Endocrinology 136, 3277–3284.
Sanchez-Gurmaches, J., Tang, Y., Jespersen, N.Z., Wallace, M., Martinez Ca-
lejman, C., Gujja, S., Li, H., Edwards, Y.J.K., Wolfrum, C., Metallo, C.M., et al.
(2018). Brown Fat AKT2 Is a Cold-Induced Kinase that Stimulates ChREBP-
Mediated De Novo Lipogenesis to Optimize Fuel Storage and Thermogenesis.
Cell Metab. 27, 195–209.e6.
Scherer, T., O’Hare, J., Diggs-Andrews, K., Schweiger, M., Cheng, B., Lindt-
ner, C., Zielinski, E., Vempati, P., Su, K., Dighe, S., et al. (2011). Brain insulin
controls adipose tissue lipolysis and lipogenesis. Cell Metab. 13, 183–194.
Schmittgen, T.D., and Livak, K.J. (2008). Analyzing real-time PCR data by the
comparative C(T) method. Nat. Protoc. 3, 1101–1108.
Schulz, T.J., Huang, P., Huang, T.L., Xue, R., McDougall, L.E., Townsend, K.L.,
Cypess, A.M., Mishina, Y., Gussoni, E., and Tseng, Y.H. (2013). Brown-fat
paucity due to impaired BMP signalling induces compensatory browning of
white fat. Nature 495, 379–383.
Silva, J.E., and Larsen, P.R. (1983). Adrenergic activation of triiodothyronine
production in brown adipose tissue. Nature 305, 712–713.
Silva, J.E., and Larsen, P.R. (1985). Potential of brown adipose tissue type II
thyroxine 50-deiodinase as a local and systemic source of triiodothyronine in
rats. J. Clin. Invest. 76, 2296–2305.
Song, Z., Xiaoli, A.M., and Yang, F. (2018). Regulation and Metabolic Signifi-
cance of De Novo Lipogenesis in Adipose Tissues. Nutrients 10, E1383.
Tran, C.M., Mukherjee, S., Ye, L., Frederick, D.W., Kissig, M., Davis, J.G.,
Lamming, D.W., Seale, P., and Baur, J.A. (2016). Rapamycin Blocks Induction
of the Thermogenic Program in White Adipose Tissue. Diabetes 65, 927–941.
Trayhurn, P. (1979). Fatty acid synthesis in vivo in brown adipose tissue, liver
and white adipose tissue of the cold-acclimated rat. FEBS Lett. 104, 13–16.
Trayhurn, P. (1980). Fatty acid synthesis in brown adipose tissue in relation to
whole body synthesis in the cold-acclimated golden hamster (Mesocricetus
auratus). Biochim. Biophys. Acta 620, 10–17.
Vaughan, C.H., Zarebidaki, E., Ehlen, J.C., and Bartness, T.J. (2014). Analysis
and measurement of the sympathetic and sensory innervation of white and
brown adipose tissue. Methods Enzymol. 537, 199–225.
Youn, D.Y., Xiaoli, A.M., Kwon, H., Yang, F., and Pessin, J.E. (2019). The sub-
unit assembly state of the Mediator complex is nutrient-regulated and is dys-
regulated in a genetic model of insulin resistance and obesity. J. Biol. Chem.
294, 9076–9083.
Yu, X.X., Lewin, D.A., Forrest, W., and Adams, S.H. (2002). Cold elicits the
simultaneous induction of fatty acid synthesis and beta-oxidation in murine
brown adipose tissue: prediction from differential gene expression and confir-
mation in vivo. FASEB J. 16, 155–168.
Zechner, R., Zimmermann, R., Eichmann, T.O., Kohlwein, S.D., Haemmerle,
G., Lass, A., and Madeo, F. (2012). FAT SIGNALS–lipases and lipolysis in lipid
metabolism and signaling. Cell Metab. 15, 279–291.
Cell Reports 31, 107598, May 5, 2020 13
Article
ll
OPEN ACCESS
STAR+METHODS
KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Anti-Fatty Acid Synthase, Clone 23 BD Bioscience Cat# 610963; RRID:AB_398276
Anti-Fatty Acid Synthase Abcam Cat# ab22759; RRID:AB_732316
Anti-UCP1 Abcam Cat# ab10983; RRID:AB_2241462
Anti-Tyrosine Hydroxylase Abcam Cat# ab75875; RRID:AB_1310786
Anti-Deiodinase-2 Abcam Cat# ab77779; RRID:AB_1951738
Anti-ACLY Proteintech Cat# 15421-1-AP; RRID:AB_2223741
Anti-ACC Cell Signaling Technology Cat# 3662; RRID:AB_2219400
Anti-SCD1 Cell Signaling Technology Cat# 2794; RRID:AB_2183099
Anti-pHSL(Ser563) Cell Signaling Technology Cat# 4139; RRID:AB_2135495
Anti-phospho PKA substrate (RRXS*/T*) Cell Signaling Technology Cat# 9624; RRID:AB_331817
Anti-pCREB(Ser133) Cell Signaling Technology Cat# 9198; RRID:AB_2561044
Anti-GAPDH Cell Signaling Technology Cat# 2118; RRID:AB_561053
Anti-MCAD Santa Cruz Biotechnology Cat# sc-365109; RRID:AB_10709904
Anti-HSP-90 Santa Cruz Biotechnology Cat# sc-7947; RRID:AB_2121235
Anti-b-Actin Sigma-Aldrich Cat# A2228; RRID:AB_476697
Anti-Rabbit IgG antibody, HRP-conjugated Millipore Cat# AP307P; RRID:AB_11212848
Anti-Mouse IgG antibody HRP-conjugated Millipore Cat# AP308P, RRID:AB_11215796
Anti-Gsa Li et al., 2016 N/A
Chemicals, Peptides, and Recombinant Proteins
Tamoxifen Sigma-Aldrich Cat# T5648
CL 316,243 Sigma-Aldrich Cat# C5976
6-Hydroxydopamine hydrochloride (6-OHDA) Sigma-Aldrich Cat# H4381
Rapamycin LC Laboratories Cat# R-5000
Ethanol American Bio Cat# AB00515
Polyethylene glycol 300 (PEG 300) Hampton Research Cat# HR2-517
Tween 80 Sigma-Aldrich Cat# P1754
Tween 20 Sigma Aldrich Cat# P1379
3,30,5-Triiodo-L-thyronine (T3) Cayman Chemicals Cat# 16028
Iodine deficient diet (0.15% PTU) ENVIGO Cat# TD.95125
Ingredient matched control diet ENVIGO Cat# TD.97350
Bovine serum albumin (fatty acid free) Sigma-Aldrich Cat# A8806
D-(+)-Glucose Sigma-Aldrich Cat# G8270
Sodium acetate Sigma-Aldrich Cat# S5636
Sodium pyruvate GIBCO Cat# 11360070
L-Glutamine GIBCO Cat# 25030081
[14C]-U-Glucose Perkin Elmer Cat# NEC042X250UC
DMEM/F-12 GIBCO Cat# 11330032
Penicilin/Streptomycin GIBCO Cat# 15140122
Normocin Invivogen Cat# ant-nr-1
Fetal bovine serum (FBS) Atlanta Biologicals Cat# S11550
Phosphate-buffered saline (PBS) GIBCO Cat# 14190144
Dibutyryl-cAMP Tocris Bioscience Cat# 1141
QIAzol Lysis Reagent QIAGEN Cat# 79306
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RESOURCE AVAILABILITY
Lead Contact
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact Dr.
Michael P Czech (Michael.Czech@umassmed.edu).
Material Availability
This study did not generate new unique reagents.
Data and Code Availability
This study did not generate any unique datasets or code.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice were housed on a 12 h light/dark schedule, and except when indicated, had free access to water and food. All of the studies
performed were approved by the Institutional Animal Care and Use Committee (IACUC) of the University of Massachusetts Medical
School. Mice with conditional GsaFlox/Flox alleles were generated as previously described (Li et al., 2016). Mice were analyzed
between 6-16 weeks of age. Both male and female mice were used for analysis. To selectively delete Gsa (Gnas) in adipocytes
from mice, homozygous GsaFlox/Flox animals were crossed to Adiponectin-Cre mice (B6;FVB-Tg(Adipoq-cre)1Evdr/J)
to generate the adipocyte-specific knockout mice referred to as Adipo-GsaKO. To inactivate Gsa in adipocytes from adult mice,
Gsa-Flox/Flox mice were crossed to Adiponectin-Cre-ERT2 mice (B6.129-Tg(Adipoq-cre/Esr1*)1Evdr/J) to generate an tamox-
ifen-inducible iAdipo-GsaKO mouse line. The induction of Gsa deletion in adipocytes of 6 week-old mature iAdipo-GsaKO female
mice were then carried out via intraperitoneal injections (i.p.) of tamoxifen, as previously described (Guilherme et al., 2017). For
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Critical Commercial Assays
Serum total T3 Calbiotech, Inc Cat# T3043T-100
Serum total T4 Calbiotech, Inc Cat# T4044T-100
Serum NEFA Fujifilm Wako Diagnostics Cat# 999-34691
Free Glycerol Reagent Sigma-Aldrich Cat# F6428
Enhanced Chemiluminescent Substrate kit Perkin Elmer Cat# NEL104001EA
iScriptTM cDNA Synthesis Kit Bio-Rad Laboratories Cat# 1708891
iTaq Universal SYBR Green Supermix Bio-Rad Laboratories Cat# 1725121
Experimental Models: Cell Lines
3T3-L1 cell line ATCC Cat# CL-173TM; RRID:CVCL_0123
Experimental Models: Organisms/Strains
Mouse: C57BL/6J The Jackson Laboratory Stock# 000664; RRID: IMSR_JAX:000664
Mouse: Gsa-Flox/Flox Li et al., 2016 N/A
Mouse: Adipoq-cre: B6;FVB-Tg(Adipoq-cre)1Evdr/J The Jackson Laboratory Stock# 010803; RRID: IMSR_JAX:010803
Mouse: Adipo-GsaKO Li et al., 2016 N/A
Mouse: Adipo-Cre: B6.129-Tg(Adipoq-cre/Esr1*)1Evdr/J The Jackson Laboratory Stock# JAX:024671, RRID:IMSR_JAX:024671
Mouse: iAdipo-GsaKO, inducible This paper N/A
Oligonucleotides
See Table S1 for primers used for qRT-PCR This paper N/A
Software and Algorithms
GraphPad Prism 8 GraphPad GraphPad Software, Inc
Image Lab 5 Analysis Software Bio-Rad Laboratories Iten# 1709690
ImageJ ImageJ ImageJ.nih.gov
Other
ChemiDocTM XRS+ Imaging System Bio-Rad Laboratories Model# 1708265
Leica DM2500 LED optical microscope Leica Microsystems Model# DM2500 LED
Leica MC170 HD camera Leica Microsystems Model# MC170 HD
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CL316243 treatment of the GsaKO mice, at the indicated weeks of age (Figure S6), both control GsaFlox/Flox and Adipo-GsaKO
were treated via i.p. injection once a day with saline vehicle or with 5 mg/kg CL316243 for 6 consecutive days. On the next day, ad-
ipose tissue was harvested and processed for histological and biochemical analyses. Serum nonesterified fatty acid (NEFA) levels
were measured using a colorimetric assay (Fujifilm Wako Diagnostics) according to the manufacturer’s instructions.
METHOD DETAILS
Adipose Tissue Denervation
To examine the contribution of adipose sympathetic activity to cold-induced DNL in adipocytes, sympathetic nerve fibers in subcu-
taneous inguinal fat from 12 week-old C57BL/6J male mice were chemically destroyed with 6-hydroxydopamine (6-OHDA) by direct
injection into adipose depots as previously described (Vaughan et al., 2014). Ten days post-injection, mice were placed at 6C for
7 days and adipose tissue depots were then harvested and reductions in tyrosine hydroxylase content in sWAT examined to confirm
efficient denervation. For surgical denervation of subcutaneous inguinal fat nerves, denervation surgery was performed on sWAT
from C57BL/6 as previously reported (Vaughan et al., 2014). Briefly, mice were anesthetized with isoflurane and then a ventral lateral
incision was made to expose sWAT nerves innervating the sWAT were either left intact (Sham control) or surgically destroyed as
described (Vaughan et al., 2014)
Animal Housing at Thermoneutral Temperature and b3-AR-agonist Treatment
For the effects of thermoneutrality on adipose tissue DNL gene expression, 8-week-old C57BL6/Jmalemice were kept either at 22C
(mild-cold) or transferred frommild-cold to 30C (thermoneutrality) and acclimated for 6weeks. Then,micewere treatedwith 5mg/kg
of b3-agonist CL316243 or phosphate-buffered saline (PBS) (one daily i.p. injection for 6 days). One day following the final injection,
adipose tissue was harvested and processed for histological and biochemical analyses.
Rapamycin Treatment
To evaluate the effects of rapamycin on cold- and CL316243-stimulated adipose DNL, mice were treated with rapamycin as previ-
ously described (Liu et al., 2016). Briefly, 12-14 week-old C57BL/6J male mice were administered with vehicle (75% saline, 10%
ethanol, 10% PEG 300, 5% Tween 80) or rapamycin (2.5 mg/kg body weight/day) once a day for 2 consecutive days. On the third
day, the mice were housed individually and placed at 4C for 7 days with daily rapamycin administration. Control mice were main-
tained at room temperature (22C). For selective activation of b3-AR, mice were treated with rapamycin (2.5 mg/kg body weight/day)
for 2 days and then treated with vehicle or with CL316243 (5 mg/kg/day) with daily rapamycin administration for 7 days. Adipose tis-
sue depots (sWAT, eWAT and BAT) were then harvested and processed for histological and biochemical analyses.
Hypothyroid Mouse Model and T3 Treatment
Mice were rendered hypothyroid induced by feeding 8 week-old C57BL6/J male mice an iodine-deficient chow diet supplemented
with 0.15% propylthiouracil (PTU, catalog TD.95125; ENVIGO) for 7 weeks. Euthyroid mice fed chow diet (ingredient matched, plus
iodine and without PTU, catalog TD.97350; ENVIGO) served as controls. This protocol has been shown to lead to a hypothyroid state
in mice fed an iodine-deficient plus PTU diet, as determined by circulating thyroxine (T4) and triiodothyronine (T3) measurements.
Serum levels of T4 and T3 were measured by ELISA (Calbiotech) after 7 weeks of treatment. Two additional groups of mice were
rendered hypothyroid as above and after 6 weeks of treatment one group were treated with CL316243 (5 mg/kg body weight)
and the other group co-treated with CL316243 (5 mg/kg body weight) plus T3 (25mg/kg of body weight) via i.p. injections during
10 days, while remaining in iodine-deficient diet plus PTU.
Lipogenesis Assay
To assess lipogenesis in white adipose tissue, sWAT explants were incubated with labeling media containing 0.2% fatty acid-free
BSA, 0.5 mM D(+)-Glucose, 0.5 mM sodium acetate, 2 mM sodium pyruvate, 2 mM L-glutamine, and 2 mCi/mL [14C]-U-glucose as
described (Danai et al., 2013; Guilherme et al., 2017; Pedersen et al., 2015). Adipose tissue explants were incubated at 37C in a
humidified incubator (5% CO2) for 4.5 h before total neutral lipid extraction. Glucose incorporation into triglyceride-fatty acids
(TG-Fatty acids) or into triglyceride-glycerol (TG-Glyceride) was then determined as previously described (Danai et al., 2013; Guil-
herme et al., 2017; Pedersen et al., 2015; Rodbell, 1964).
Adipocyte Cell Cultures
For experiments with 3T3-L1 mature adipocytes, 3T3-L1 fibroblasts were obtained from ATCC, maintained and differentiated into
adipocytes as previously described (Pedersen et al., 2015). On the seventh day after differentiation, mature adipocytes were treated
with CL316243 as stated in figure legend for the indicated period of time. Cells were then harvested and total RNA extracted and used
for quantitative RT-PCR analysis. For the experiment with primary adipocytes, primary subcutaneous white fat stromal vascular frac-
tion (SVF) from 3 weeks of age C57BL6/J mice was isolated according to published methods (Danai et al., 2015; Guilherme et al.,
2017). Briefly, primary SVF cells were cultured in DMEM/F12 containing 10% Fetal Bovine Serum (FBS), 100 U mL1 penicillin,
0.1 mg mL1 streptomycin and 0.1 mg mL-1 normocin (maintenance medium) until full confluence. Then, adipocyte differentiation
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was induced in preadipocyte cultures as previously described (Guilherme et al., 2017). To examine the effects of b3-AR activation on
DNL gene expression in mature primary adipocytes, at day 7th-post differentiation adipocytes were incubated with the indicated
CL316243 concentrations for 6h on the seventh day post-differentiation, followed by total protein or RNA extractions for immuno-
blotting or qPCR quantification.
Dibutyryl-cAMP Treatment
To evaluate the effects of acute treatment of dibutyryl-cAMP in sWAT adipocytes, subcutaneous preadipocytes in the SVF cells from
3 weeks of age Gsa-Flox/Flox and Adipo-GsaKO mice were cultured in maintenance medium until full confluence. Cells were then
differentiated into adipocyte and at the 7th days-post differentiation, control and GsaKO mature adipocytes were incubated with
vehicle, CL316243 0.2 mM or dibutyryl-cAMP 1 mM and their effects on lipolysis, and UCP1 expression levels examined. Media
from these cells were also collected after 2.5h of incubation and the levels of glycerol released in the media determined using color-
imetric assay to measure free glycerol. To assess the effects of dibutyryl-cAMP treatment on adipose tissue deleted of Gsa, sWAT
explants from Gsa-Flox/Flox and Adipo-GsaKOmice were incubated at 37C with media containing CL316243 0.2 mM or dibutyryl-
cAMP for 2.5 h and the effect of these agonist on phospho-PKA substrate protein levels and on lipolysis determined by anti-PKAS
immunoblot and colorimetric assay to measure free glycerol levels.
Western Blot Analysis
Cultured adipocytes or adipose tissue were lysed. Total lysates were resolved by SDS-PAGE and electrotransferred to nitrocellulose
membranes. Membranes were incubated with the indicated antibodies overnight at 4C. Immunoblots were washed with TBS-T
(0.2% Tween 20 in Tris-buffered saline), incubated with horseradish peroxidase (HRP) anti-mouse or anti-rabbit secondary antibody
and visualized using an enhanced chemiluminescent substrate kit (Perkin Elmer) and images taken using the ChemiDoc Imaging Sys-
tem XRS+ with Image Lab 5.0 software. Densitometric analyses of the protein bands were performed using ImageJ Software.
RNA Isolation and RT-qPCR
Total RNA was isolated from mouse tissue using QIAzol Lysis Reagent (QIAGEN) following the manufacturer’s instructions. cDNA
was synthesized from isolated RNA using iScript cDNA Synthesis Kit (BioRad). Quantitative RT-PCR was performed using iQ Sybr-
Green supermix (BioRad) on a BioRad CFX97 RT-PCR system and analyzed as previously described (Livak and Schmittgen, 2001;
Schmittgen and Livak, 2008). 36B4, Hprt, Gapdh, 18S and B2m served as controls for normalization. Primer sequences used for
qRT–PCR analyses are listed in Table S1.
Histological Analysis
For immunohistochemistry (IHC), tissue samples were fixed in 4% paraformaldehyde and embedded in paraffin. Sectioned slides
were then stained for FASN (Abcam) and UCP1 (Abcam) at the UMASSMedical School Morphology Core. Photos of stained sections
were taken with a Leica DM2500 LED optical microscope equipped with a Leica MC170 HD camera.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data were analyzed in GraphPad Prism 8 (GraphPad Software, Inc.). Student’s t-test or the Mann–Whitney U-test was employed for
the parametric and non-parametric data, respectively. Comparisons betweenmore than 2 groups were performed using ANOVAwith
Tukey’s post hoc test. The significance level was set at p % 0.05. Information on replicates/ error bars is included in the figure
legends.
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